Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Deciphering the Impact of Immunological Aging in CLL CAR T Cell Therapy

Julia Han Noll, Humza Hemani, Jiang Yuan Li, Kevin R. Amses, Bruce Levine, Carl H. June, Nan-Ping Weng, Joseph A. Fraietta

Blood (2024) 144 (Supplement 1): 2051.

https://doi.org/10.1182/blood-2024-200721

Published: 2024

Journal Articles

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Zhenkun Wang, Zhi-Wei Zhang, Zhong-Shi Lyu, Tong Xing, Mi Liang, Mengzhu Shen, Chen-Yuan Li, Xin-Yan Zhang, Dan-Dan Chen, Ya-Zhe Wang, Li-Juan Hu, Hao Jiang, Qian Jiang, Yuan Kong, Xiao-Jun Huang

Blood (2024) 144 (Supplement 1): 2684.

https://doi.org/10.1182/blood-2024-201354

Published: 2024

Journal Articles

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Nina Kim, Xin Wang, Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne D. Pulte, Marc R. Theoret, R. Angelo De Claro, Kelly J. Norsworthy

Blood (2024) 144 (Supplement 1): 1829.

https://doi.org/10.1182/blood-2024-208514

Published: 2024

Journal Articles

TGF-β Pathway Inhibition Improves Hematopoietic Deficiency and Immune Imbalance By Repairing Endothelial Progenitor Cell Function in Aplastic Anemia

Xinyan Zhang, Li-Ping Guo, Jin-Song Jia, Ya-Zhe Wang, Mi Liang, Mengzhu Shen, Zhenkun Wang, Chen-Yuan Li, Zhong-Shi Lyu, Tong Xing, Zhi-Wei Zhang, Yuan-Yuan Zhang, Xiao-Jun Huang, Yuan Kong

Blood (2024) 144 (Supplement 1): 4074.

https://doi.org/10.1182/blood-2024-201438

Published: 2024

Journal Articles

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Robert Q. Le, Donna Przepiorka, Haiyan Chen, Yuan Li Shen, E. Dianne Pulte, Kelly Norsworthy, Marc R. Theoret, R. Angelo De Claro

Blood (2024) 144 (2): 206–215.

https://doi.org/10.1182/blood.2023023313

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial

Wenrui Yang, Xin Zhao, Guangxin Peng, Huihui Fan, Kang Zhou, Lei Ye, Jianping Li, Yuan Li, Liping Jing, Li Zhang, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 1348.

https://doi.org/10.1182/blood-2023-179958

Published: 2023

Journal Articles

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Xin Zhao, Jianping Li, Huihui Fan, Liping Jing, Li Zhang, Kang Zhou, Wenrui Yang, Yuan Li, Yang Yang, Lei Ye, Guangxin Peng, Youzhen Xiong, Jun Shi, Fengkui Zhang

Blood (2023) 142 (Supplement 1): 4087.

https://doi.org/10.1182/blood-2023-190948

Published: 2023

Journal Articles

Metabolomics-Driven Systematic Research Reveals Different Metabolomic and Lipidomic Profiling of Bone Marrow Plasma in Patients with Multiple Myeloma

Ziang Zhu, Yang Li, Jin-Yuan Li, Han-Ying Huang, Chen Shuzhao, Yang Liu, Yang Liang, Lingling Shu

Blood (2023) 142 (Supplement 1): 6571.

https://doi.org/10.1182/blood-2023-180385

Published: 2023

Journal Articles

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Blood (2022) 140 (Supplement 1): 1974–1976.

https://doi.org/10.1182/blood-2022-156764

Published: 2022

Journal Articles

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Vishal Bhatnagar, Bindu Kanapuru, Laura Fernandes, Ting-Yu Chen, Mallorie H. Fiero, Erica Horodniceanu, Nicole Gormley, Catherine Lerro, Fatima Rizvi, Yuan-Li Shen, Felice Yang, Anna Barcellos, Andrew J. Belli, Eric Hansen, Ching-Kun Wang, Donna Rivera, Paul Kluetz

Blood (2022) 140 (Supplement 1): 7156–7157.

https://doi.org/10.1182/blood-2022-166842

Published: 2022

Journal Articles

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Wenrui Yang, Xin Zhao, Xu Liu, Youzhen Xiong, Huihui Fan, Guangxin Peng, Li Zhang, Jianping Li, Lei Ye, Kang Zhou, Yuan Li, Yang Yang, Yingchang Mi, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8663.

https://doi.org/10.1182/blood-2022-166616

Published: 2022

Journal Articles

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Liping Jing, Yingchang Mi, Huihui Fan, Wenrui Yang, Yuan Li, Jianping Li, Li Zhang, Xin Zhao, Kang Zhou, Lei Ye, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5811–5812.

https://doi.org/10.1182/blood-2022-168380

Published: 2022

Journal Articles

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Xin Zhao, Li Zhang, Bing Han, Tiantian Zhang, Xu Liu, Miao Chen, Changping Li, Huijie Huang, Liping Jing, Kang Zhou, Guangxin Peng, Yuan Li, Jianping Li, Lei Ye, Huihui Fan, Wenrui Yang, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5805–5806.

https://doi.org/10.1182/blood-2022-167951

Published: 2022

Journal Articles

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Xiyan Wang, Xiaofan Liu, Yueshen Ma, Jiao Wang, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Hui Yuan Li, Feng Xue, Changping Li, Zhen Song, Lei Zhang, Renchi Yang

Blood (2022) 140 (Supplement 1): 2214–2215.

https://doi.org/10.1182/blood-2022-164457

Published: 2022

Journal Articles

Immunotyping of ITP Based on Different Platelet Destruction Mechanism Are Associated with Response to Splenectomy

Hui Yuan Li, Xueqing Dou, Yunfei Chen, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 2211.

https://doi.org/10.1182/blood-2022-159829

Published: 2022

Journal Articles

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Xin Zhao, Baohang Zhang, Jianping Li, Huihui Fan, Yuan Li, Wenrui Yang, Liping Jing, Li Zhang, Kang Zhou, Youzhen Xiong, Lei Ye, Yingchang Mi, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 2940.

https://doi.org/10.1182/blood-2022-169378

Published: 2022

Journal Articles

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Wenrui Yang, Xu Liu, Xin Zhao, Li Zhang, Guangxin Peng, Lei Ye, Kang Zhou, Yuan Li, Jianping Li, Huihui Fan, Yang Yang, Youzhen Xiong, Liping Jing, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 8655.

https://doi.org/10.1182/blood-2022-164574

Published: 2022

Journal Articles

Integrated Analysis of Key Genes for FGFR1 Knockdown in Mantle Cell Lymphoma Cell Line (Z-138)

Xue Wu, PhD, Yuan Li, PhD, Baoan Chen, MDPhD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-143311

Published: 2020

Journal Articles

An Accurate Prognostic Survival Model of Survival Based on Expression of Genes Involved in Plasma Cell Metabolism

Yang Liang, MD, Han-ying Huang, Yun Wang, MD PhD, Weida Wang, MD PhD, Jin-Yuan Li, Ling-ling Shu

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-140930

Published: 2020

Journal Articles

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

Huihui Liu, PhD, Zhengyu Yu, MD, Bo Tang, MD, Shengchao Miao, MD, Chenchen Qin, Yuan Li, MD, Zeyin Liang, MD, Yang Zhang, Hanyun Ren, MD, Yujun Dong, MD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-141877

Published: 2020

NARROW

Deciphering the Impact of Immunological Aging in CLL CAR T Cell Therapy

Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy

Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

TGF-β Pathway Inhibition Improves Hematopoietic Deficiency and Immune Imbalance By Repairing Endothelial Progenitor Cell Function in Aplastic Anemia

Complete remission with partial hematological recovery as a palliative endpoint for treatment of acute myeloid leukemia

Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial

Avatrombopag Is Effective in First-Line Treatment of Severe Aplastic Anemia: Early Outcomes of a Prospective Study

Metabolomics-Driven Systematic Research Reveals Different Metabolomic and Lipidomic Profiling of Bone Marrow Plasma in Patients with Multiple Myeloma

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Patient- and Clinician-Reported Performance Status in Patients with Multiple Myeloma Treated in the United States Using Real World Data

Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study

Hematological Response to Avatrombopag Switch in Thrombopoietin Receptor Agonist-Refractory Aplastic Anemia

Immunosuppressive Therapy-Response Predicting Scoring System for Severe Aplastic Anemia

Predictive Factors of Relapse for Primary Immune Thrombocytopenia in Adults: A Single-Center Retrospective Cohort Analysis

Immunotyping of ITP Based on Different Platelet Destruction Mechanism Are Associated with Response to Splenectomy

Avatrombopag Added to Standard Immunosuppressive Therapy for Severe Aplastic Anemia

Anti-Human T Lymphocyte Porcine Immunoglobulin Combined with Cyclosporine As First-Line Immunosuppressive Therapy for Severe Aplastic Anemia in China: A Large Single-Center, 10-Year Retrospective Study

Integrated Analysis of Key Genes for FGFR1 Knockdown in Mantle Cell Lymphoma Cell Line (Z-138)

An Accurate Prognostic Survival Model of Survival Based on Expression of Genes Involved in Plasma Cell Metabolism

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only